Bringing Regulatory‐Style Benefit‐Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision‐Making
Journal of Evaluation in Clinical Practice · 2026
DOI: 10.1111/jep.70558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Evaluation in Clinical Practice, 2026. Verfasst von Sebastián Garcia-Zamora und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Delta Clinic, Rosario, Argentina. Hauptthemen laut MEDLINE: Decision Making, Shared. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Drug regulatory agencies now evaluate treatments by weighing benefits against harms in a structured, transparent process, yet the summaries that reach clinicians at the point of care still fragment efficacy and safety into separate statistics that hide absolute effects, mask how results vary across patients, and omit individual preferences.
Objective
To propose a structured evidence synthesis method that translates benefit‐risk evaluation logic into a traceable, clinician‐facing summary for shared decision‐making.
Methods
Drawing on established benefit‐risk methods (BRAT, MCDA), value‐based healthcare principles, and clinical decision science, we describe a seven‐domain value structure, a workflow centred on an effects table that presents benefits and harms as absolute effects per 1000 patients, and two summary metrics (Net Clinical Benefit, NCB, and Trade‐off Index, TIX) computed using simple arithmetic.
Results
We present the proposed framework, compare it with existing approaches, and outline a staged development pathway, standardisation, pilot testing, and prospective evaluation, required to establish feasibility, reproducibility, and impact on decision quality.
Conclusion
The methodology bridges benefit‐risk evaluation and clinical conversations by making multi‐outcome trade‐offs explicit and testable under varying assumptions. In practice, the underlying evidence synthesis is performed within guideline or review processes, while clinicians use the resulting summary to structure bedside discussions and incorporate patient priorities. Whether this approach improves alignment between treatment choices and patient values is an empirical question this concept paper poses but does not answer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Delta Clinic, Rosario, Argentina.
- Global Medical Safety, Organon, Brussels, Belgium.
ORCID-Profile: Miguel Hernán Vicco
Zitieren
APA
Garcia-Zamora, S., Tavares-Da-Silva, F., Labudovic, I., & Vicco, M. H. (2026). Bringing Regulatory‐Style Benefit‐Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision‐Making. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/jep.70558
Vancouver
Garcia-Zamora S, Tavares-Da-Silva F, Labudovic I, Vicco MH. Bringing Regulatory‐Style Benefit‐Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision‐Making. Journal of Evaluation in Clinical Practice. 2026. doi:10.1111/jep.70558
BibTeX
@article{GarciaZamora2026,
author = {Garcia-Zamora, Sebastián and Tavares-Da-Silva, Fernanda and Labudovic, Ivana and Vicco, Miguel Hernán},
title = {Bringing Regulatory‐Style Benefit‐Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision‐Making},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
doi = {10.1111/jep.70558}
}
EUVIMED